PharmExec Blog
Follow Us
RSS
Bookstore
Technology News- BioPharm News
- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
- Clinical Trials News
- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Author Archives: Andrew Sheivachman
AZ’s First Corporate Blog Falls Flat
Currently, if patients or doctors look for specific drug information on AZ Health Connections, AstraZeneca’s new corporate communications blog, they won’t find any. And that’s exactly how AZ—along with pretty much every other pharma company engaged in the social media sphere—wants it.
“The one area we’re trying not to engage is specific questions about disease state,” [...]
Posted in E-Media Tagged AstraZeneca, Community, Company, Food and Drug Administration, Health care, social media, Virtual community, Washington DC 2 Comments
Pharma Celebrates its Own
At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage.
“The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon Health [...]
Prix Galien Push for Private/Public Collaboration
Preceding the presentation of the 2009 Prix Galien USA prizes, last Tuesday, a round table discussion was conducted at the American Museum of Natural History on the subject of how public and private collaboration can increase innovation and contribute to saving lives around the world. The talk included Leonard Bell of Alexion Pharmaceuticals, Barry Bloom [...]
Merck, Schering-Plough Merger Boosts Global Profile, but Questions Linger